Epilepsy-related prescription drugs and medical supplies cost sharing limitation provision

This bill limits out-of-pocket costs for people with epilepsy who have health insurance in Minnesota. It adds epilepsy to the list of qualifying chronic diseases (alongside diabetes, asthma, and allergies requiring epinephrine) under existing rules that cap co-pays and coinsurance for related prescription drugs and medical supplies. The law defines "related medical supplies" to include items like epinephrine auto-injectors and epilepsy-specific medications. It will take effect January 1, 2027, for health plans offered, issued, or renewed on or after that date.